Thromb Haemost 1975; 33(02): 157-162
DOI: 10.1055/s-0038-1647834
Original Article
Schattauer GmbH

The British System for Anticoagulant Control[*]

L Poller
1   Withington Hospital, Manchester WHO Collaborating Centre for Anticoagulant Control Regents**
› Author Affiliations
Further Information

Publication History

Received 15 January 1975

accepted 15 January 1975

Publication Date:
02 July 2018 (online)

Summary

The British system for anticoagulant control based on the use of a national reagent with a national system of reporting supported by national quality control using lyophilized plasma preparations appears to offer a model which many countries abroad seem interested in adopting to solve their own national problems. Good progress has already been made in this direction in some Commonwealth countries and in South Africa. At a symposium at the 3rd Mediterranean Congress on Thromboembolism in 1973 invited participants from all over the world agreed to set up an International Study Group to provide an international organisation for anticoagulant control, and an encouraging start has been made.

* Presented at the Meeting of ISTH, Vienna, July, 1973.


** Now designated the World Health Organisation Collaborating Centre for Research and Reference on Anticoagulant Control Reagents.


 
  • References

  • 1 Poller L. The British comparative thromboplastin: The use of the national thromboplastin reagent for uniformity of laboratory control of oral anticoagulants and expression of results. Association of Clinical Pathologists: Broadsheet No. 71 1970
  • 2 Hills M, Ingram G. I. C. Monitoring successive batches of British Comparative Thromboplastin. British Journal of Haematology 1973; 25: 445
  • 3 Leck I, Thomson J. M, Poller L. Quality control trials in the national reference thromboplastin scheme. British Journal of Haematology 1973; 25: 453